An LPA1 agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

UCM-05194 (ammonium salt)

Item No. 41682

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
benzenedecanoic acid, (1S)-1-(bromomethyl)-2-(phosphonooxy)ethyl ester, monoammonium salt
Molecular Formula
C19H29BrO6P • NH4
Formula Weight
482.4
Purity
≥95%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMSO: SolubleEthanol: Slightly solubleWater: Soluble
SMILES
O=C(CCCCCCCCCC1=CC=CC=C1)O[C@@H](COP(O)([O-])=O)CBr.[NH4+]
InChi Code
InChI=1S/C19H30BrO6P.H3N/c20-15-18(16-25-27(22,23)24)26-19(21)14-10-5-3-1-2-4-7-11-17-12-8-6-9-13-17;/h6,8-9,12-13,18H,1-5,7,10-11,14-16H2,(H2,22,23,24);1H3/t18-;/m1./s1
InChi Key
UKZAXCXBQFDZCW-GMUIIQOCSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $105

    Add

    5 mg

    $471

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    UCM-05194 is an agonist of lysophosphatidic acid receptor 1 (LPA1).1 It induces calcium mobilization in RH7777 cells expressing LPA1 (EC50 = 0.24 µM). It is selective for LPA1 over LPA2 and LPA3 at 10 µM and is 10-fold selective over LPA5 and 50-fold selective over LPA4, LPA6, and autotaxin. UCM-05194 (1 µM) induces neurite retraction in, and migration of, B103 rat neuroblastoma cells overexpressing LPA1. It induces receptor internalization and neuronal desensitization in the same cells when used at a concentration of 1 µM and reduces the firing activity of primary rat neonatal dorsal root ganglia (DRG) neurons with repeated application at 10 µM. UCM-05194 (10 mg/kg) reduces acetic acid-induced writhing and hind paw mechanical hypersensitivity in mice.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. González-Gil, I., Zian, D., Vázquez-Villa, H., et al. A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration. J. Med. Chem. 63(5), 2372-2390 (2020).